Fanuc Corporation - FANUY

FANUY Returns vs S&P 500 ⓘ

ticker	1 day return %	1 week return %	1 month return %	3 months return %	6 months return %	1 year return %	3 years return %	5 years return %	10 years return %	maximum return %
FANUY	0.3	0.9	17.1	19.0	10.0	3.0	-23.6	-19.8	-48.4	28.8
S&P 500	0.5	2.1	2.4	5.5	10.1	25.8	38.7	84.0	198.2	34547.3

Compare FANUY with other assets →

Returns Charts ⓘ

Interactive Price Chart

Our interactive price chart includes various drawing tools to help you analyze the product more effectively. Below is a quick guide on how to use these tools: Full Guideline

Real-time Full Quote

Attribute	Value
symbol	FANUY
name	Fanuc Corporation
price	15
changes percentage	0.2674
change	0.04
day low	14.82
day high	15
year high	15.54
year low	12.46
market cap	28068812670
price avg 50	13.3314
price avg 200	13.81065
exchange	PNK
volume	22216
avg volume	502305
open	14.82
previous close	14.96
eps	0.47
pe	31.91
earnings announcement	2025-01-27T06:00:00.000+0000
shares outstanding	1871254178
timestamp	2025-01-23 20:50:21

Financial Statements ⓘ

We derive the score of a company's financial statements by evaluating the weighted average sentiment across key within the statements. The cumulative score, normalized to a sum of 1, serves as a metric for assessing the company's performance during the specified period. A higher score indicates stronger performance. However, it's crucial to note that while this score provides valuable insights, it is just one of many factors to consider when making informed investment decisions. A holistic evaluation, considering various aspects of the company's financial health and market conditions, is essential for a well-rounded investment strategy.

Overall Annual Financial Health: 53.7%

Overall Quarterly Financial Health: 41.0%

Income Statements ⓘ

• Annual Income Statement

Note: The years below are fiscal years in accounting.

	2024	2023	Y/Y change %
0000000000
revenue	795274000000	851956000000	-6.65
gross profit	266299000000	316523000000	-15.87
gross profit ratio	0.33	0.37	-9.87
research and development expenses	0	51941000000	-100.00
operating expenses	124380000000	125164000000	-0.63
interest income	4549000000	3840000000	18.46
interest expense	0	0	NaN
ebitda	190920000000	240548000000	-20.63
ebitdaratio	0.24	0.28	-14.97
operating income	141919000000	191359000000	-25.84
operating income ratio	0.18	0.22	-20.55
net income	133159000000	170587000000	-21.94
net income ratio	0.17	0.2	-16.38
eps	140.23	178.55	-21.46

Overall Score of Annual Income Statement

0.12 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Revenue Growth: revenue decreased to 795,274 million in 2024 from 851,956 million in 2023 representing a change of -6.65%. This indicates a sales shrinking, which is a negative sign for the company.

  Gross Profit: Gross Profit decreased to 266,299 million in 2024 from 316,523 million in 2023 representing a change of -15.87%. This indicates a sales profitability decline, which is a negative sign for the company.

  Research and Development (R&D) Expenses: R&D Expenses decreased to 0 million in 2024 from 51,941 million in 2023 representing a change of -100.0%. This shows that the company decreased investment in innovation and product development, which is not a good sign for long-term growth.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) decreased to 190,920 million in 2024 from 240,548 million in 2023 representing a change of -20.63%. The decrease in EBITDA indicates declined operational efficiency and profitability.

  Operating Income: Operating income decreased to 141,919 million in 2024 from 191,359 million in 2023 representing a change of -25.84%. The decrease in operating income indicates worse operational performance and decreased profitability.

  Net Income: Net income decreased to 133,159 million in 2024 from 170,587 million in 2023 representing a change of -21.94%. The decrease in net income shows worsen profitability and indicates that the company is generating less profit for each dollar of revenue.

  Earnings per Share (EPS): EPS increased to 140.23 in 2024 from 140.23 in 2023 representing a change of -21.46%. This indicates that the company's earnings are decreasing and it is becoming less profitable on a per-share basis.

• 📈 Positive Indicators

  Operating Expenses: Operating Expenses decreased to 124,380 million in 2024 from 125,164 million in 2023 representing a change of -0.63%. The decrease in operating expenses can be attributed to various factors such as improved profitability, cost optimization and financial stability, lower operating expenses can be positive indicators.

• Quarterly Income Statement

Note: The years below are fiscal years in accounting.

	2025Q1	2024Q4	Q/Q change %
0000000000
revenue	195100000000	198749000000	-1.84
gross profit	67762000000	68773000000	-1.47
gross profit ratio	0.35	0.35	0.37
research and development expenses	0	12307000000	-100.00
operating expenses	28531000000	34277000000	-16.76
interest income	1629000000	1271000000	28.17
interest expense	0	0	NaN
ebitda	45208250000	46746250000	-3.29
ebitdaratio	0.23	0.24	-2.08
operating income	32958000000	34496000000	-4.46
operating income ratio	0.17	0.17	-2.67
net income	28803000000	34819000000	-17.28
net income ratio	0.15	0.18	-15.73
eps	30.46	36.8	-17.23

Overall Score of Quarterly Income Statement

0.12 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Revenue Growth: revenue decreased to 195,100 million in 2025Q1 from 198,749 million in 2024Q4 representing a change of -1.84%. This indicates a sales shrinking, which is a negative sign for the company.

  Gross Profit: Gross Profit decreased to 67,762 million in 2025Q1 from 68,773 million in 2024Q4 representing a change of -1.47%. This indicates a sales profitability decline, which is a negative sign for the company.

  Research and Development (R&D) Expenses: R&D Expenses decreased to 0 million in 2025Q1 from 12,307 million in 2024Q4 representing a change of -100.0%. This shows that the company decreased investment in innovation and product development, which is not a good sign for long-term growth.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) decreased to 45,208 million in 2025Q1 from 46,746 million in 2024Q4 representing a change of -3.29%. The decrease in EBITDA indicates declined operational efficiency and profitability.

  Operating Income: Operating income decreased to 32,958 million in 2025Q1 from 34,496 million in 2024Q4 representing a change of -4.46%. The decrease in operating income indicates worse operational performance and decreased profitability.

  Net Income: Net income decreased to 28,803 million in 2025Q1 from 34,819 million in 2024Q4 representing a change of -17.28%. The decrease in net income shows worsen profitability and indicates that the company is generating less profit for each dollar of revenue.

  Earnings per Share (EPS): EPS increased to 30.46 in 2025Q1 from 30.46 in 2024Q4 representing a change of -17.23%. This indicates that the company's earnings are decreasing and it is becoming less profitable on a per-share basis.

• 📈 Positive Indicators

  Operating Expenses: Operating Expenses decreased to 28,531 million in 2025Q1 from 34,277 million in 2024Q4 representing a change of -16.76%. The decrease in operating expenses can be attributed to various factors such as improved profitability, cost optimization and financial stability, lower operating expenses can be positive indicators.

Balance Sheets ⓘ

• Annual Balance Sheet

Note: The years below are fiscal years in accounting.

	2024	2023	Y/Y change %
0000000000
total assets	1926037000000	1873536000000	2.80
total liabilities	206837000000	245981000000	-15.91
total equity	1719200000000	1627555000000	5.63
cash and cash equivalents	522979000000	476953000000	9.65
short term investments	16100000000	52275000000	-69.20
long term investments	187369000000	159500000000	17.47
total current assets	1076265000000	1061740000000	1.37
total non current assets	849772000000	811796000000	4.68
total current liabilities	156890000000	183955000000	-14.71
total non current liabilities	49947000000	62026000000	-19.47
common stock	69014000000	69014000000	0.00
retained earnings	1540398000000	1515662000000	1.63
total debt	6423000000	5105000000	25.82

Overall Score of Annual Balance Sheet

0.78 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Total Assets: Total Assets increased to 1,926,037 million in 2024 from 1,873,536 million in 2023 representing a change of 2.8%. Suggesting a growth in asset holdings.

  Total Liabilities: Total Liabilities decreased to 206,837 million in 2024 from 245,981 million in 2023 representing a change of -15.91%. This indicates a decrease in overall liabilities.

  Total Equity: Total Equity increased to 1,719,200 million in 2024 from 1,627,555 million in 2023 representing a change of 5.63%. This indicates an increase in shareholders' equity.

  Cash And Cash Equivalents: Cash And Cash Equivalents increased to 522,979 million in 2024 from 476,953 million in 2023 representing a change of 9.65%. This indicates an increase in available liquid assets.

  Total Current Assets: Total Current Assets increased to 1,076,265 million in 2024 from 1,061,740 million in 2023 representing a change of 1.37%. This indicates a better liquidity position.

  Total Current Liabilities: Total Current Liabilities decreased to 156,890 million in 2024 from 183,955 million in 2023 representing a change of -14.71%. This indicates a lower short-term debt burden.

  Retained Earnings: Retained Earnings increased to 1,540,398 million in 2024 from 1,515,662 million in 2023 representing a change of 1.63%. This indicates an accumulated profits.

• 📉 Negative Indicators

  Short Term Investments: Short Term Investments decreased to 16,100 million in 2024 from 52,275 million in 2023 representing a change of -69.2%. This indicates a decrease in short-term investment holdings.

  Total Debt: Total Debt increased to 6,423 million in 2024 from 5,105 million in 2023 representing a change of 25.82%. This indicates an increase in overall debt burden.

• Quarterly Balance Sheet

Note: The years below are fiscal years in accounting.

	2025Q1	2024Q4	Q/Q change %
0000000000
total assets	1952557000000	1926037000000	1.38
total liabilities	156571000000	206837000000	-24.30
total equity	1745559000000	1719200000000	1.53
cash and cash equivalents	562603000000	526881000000	6.78
short term investments	16100000000	12198000000	31.99
long term investments	174570000000	184434000000	-5.35
total current assets	1106101000000	1076265000000	2.77
total non current assets	846456000000	849772000000	-0.39
total current liabilities	156571000000	156890000000	-0.20
total non current liabilities	0	49947000000	-100.00
common stock	69014000000	69014000000	0.00
retained earnings	1508568000000	1540398000000	-2.07
total debt	7615000000	6423000000	18.56

Overall Score of Quarterly Balance Sheet

0.78 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Total Assets: Total Assets increased to 1,952,557 million in 2025Q1 from 1,926,037 million in 2024Q4 representing a change of 1.38%. Suggesting a growth in asset holdings.

  Total Liabilities: Total Liabilities decreased to 156,571 million in 2025Q1 from 206,837 million in 2024Q4 representing a change of -24.3%. This indicates a decrease in overall liabilities.

  Total Equity: Total Equity increased to 1,745,559 million in 2025Q1 from 1,719,200 million in 2024Q4 representing a change of 1.53%. This indicates an increase in shareholders' equity.

  Cash And Cash Equivalents: Cash And Cash Equivalents increased to 562,603 million in 2025Q1 from 526,881 million in 2024Q4 representing a change of 6.78%. This indicates an increase in available liquid assets.

  Short Term Investments: Short Term Investments increased to 16,100 million in 2025Q1 from 12,198 million in 2024Q4 representing a change of 31.99%. This indicates an increase in short-term investment holdings.

  Total Current Assets: Total Current Assets increased to 1,106,101 million in 2025Q1 from 1,076,265 million in 2024Q4 representing a change of 2.77%. This indicates a better liquidity position.

  Total Current Liabilities: Total Current Liabilities decreased to 156,571 million in 2025Q1 from 156,890 million in 2024Q4 representing a change of -0.2%. This indicates a lower short-term debt burden.

• 📉 Negative Indicators

  Retained Earnings: Retained Earnings decreased to 1,508,568 million in 2025Q1 from 1,540,398 million in 2024Q4 representing a change of -2.07%. This indicates an accumulated losses.

  Total Debt: Total Debt increased to 7,615 million in 2025Q1 from 6,423 million in 2024Q4 representing a change of 18.56%. This indicates an increase in overall debt burden.

Cashflow Statements ⓘ

• Annual Cashflow Statement

Note: The years below are fiscal years in accounting.

	2024	2023	Y/Y change %
0000000000
net change in cash	49928000000	-97702000000	151.10
operating cash flow	171764000000	99505000000	72.62
free cash flow	117880000000	52439000000	124.79
capital expenditure	-53884000000	-47066000000	-14.49
depreciation and amortization	49001000000	49189000000	-0.38
deferred income tax	0	0	NaN
stock based compensation	0	0	NaN
accounts payables	-18812000000	4632000000	-506.13
inventory	12556000000	-91119000000	113.78
acquisitions net	0	0	NaN
investments in property plant and equipment	-53884000000	-47066000000	-14.49
net cash used for investing activites	-13563000000	-77998000000	82.61
debt repayment	0	0	NaN
common stock issued	0	0	NaN
common stock repurchased	-28391000000	-24436000000	-16.19
dividends paid	-90096000000	-96485000000	6.62
net cash used provided by financing activities	-122514000000	-127924000000	4.23
cash at end of period	526881000000	476953000000	10.47
accounts receivables	24798000000	-3375000000	834.76
cash at beginning of period	476953000000	574655000000	-17.00

Overall Score of Annual Cashflow Statement

0.71 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Net Change in Cash: Net Change in Cash increased to 49,928 million in 2024 from -97,702 million in 2023 representing a change of 151.1%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.

  Operating Cash Flow: Operating Cash Flow increased to 171,764 million in 2024 from 99,505 million in 2023 representing a change of 72.62%. This indicates that the company generated more cash from its core business operations.

  Free Cash Flow: Free Cash Flow increased to 117,880 million in 2024 from 52,439 million in 2023 representing a change of 124.79%. This indicates an increase in cash generated after accounting for capital expenditures.

  Capital Expenditure: Capital Expenditure decreased to -53,884 million in 2024 from -47,066 million in 2023 representing a change of -14.49%. This indicates a possible improved efficiency or a shift in the company's strategic priorities.

  Dividends Paid: Dividends Paid increased to -90,096 million in 2024 from -96,485 million in 2023 representing a change of 6.62%. This indicates a stronger financial position, more confidence in future prospects, and a better commitment to returning value to shareholders.

• 📉 Negative Indicators

  Accounts Payables: The absolute value of Accounts Payables increased to 18,812 million in 2024 from 4,632 million in 2023 representing a change of -506.13%. This indicates that the company has increased its outstanding obligations to its suppliers.

  Accounts Receivables: Accounts Receivables increased to 24,798 in 2024 from -3,375 million in 2023 representing a change of 834.76%. This suggests that the company is less capable of collecting payments from its customers.

• Quarterly Cashflow Statement

Note: The years below are fiscal years in accounting.

	2025Q1	2024Q4	Q/Q change %
0000000000
operating cash flow	0	48276000000	-100.0
free cash flow	0	33800000000	-100.0
capital expenditure	0	-14476000000	100.0
depreciation and amortization	0	12827500000	-100.0
deferred income tax	0	0	NaN
stock based compensation	0	0	NaN
accounts receivables	0	70500000	-100.0
accounts payables	0	0	NaN
inventory	0	13824000000	-100.0
acquisitions net	0	0	NaN
investments in property plant and equipment	0	-14476000000	100.0
net cash used for investing activites	0	10100000000	-100.0
debt repayment	0	0	NaN
common stock issued	0	0	NaN
common stock repurchased	0	-13697500000	100.0
dividends paid	0	-19175500000	100.0
net cash used provided by financing activities	0	-33405500000	100.0
net change in cash	0	26505500000	-100.0
cash at end of period	0	26505500000	-100.0
cash at beginning of period	0	0	NaN

Overall Score of Quarterly Cashflow Statement

0.33 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Net Change in Cash: Net Change in Cash decreased to 0 million in 2025Q1 from 26,506 million in 2024Q4 representing a change of -100.0%. Indicating a declined ability to generate cash from the company's operations or its cash flow position.

  Operating Cash Flow: Operating Cash Flow decreased to 0 million in 2025Q1 from 48,276 million in 2024Q4 representing a change of -100.0%. This indicates that the company generated less cash from its core business operations.

  Free Cash Flow: Free Cash Flow decreased to 0 million in 2025Q1 from 33,800 million in 2024Q4 representing a change of -100.0%. This indicates a decrease in cash generated after accounting for capital expenditures.

  Capital Expenditure: Capital Expenditure increased to 0 million in 2025Q1 from -14,476 million in 2024Q4 representing a change of 100.0%. This indicates an increase in the cash outflow required for acquiring or improving long-term assets.

• 📈 Positive Indicators

  Accounts Receivables: Accounts Receivables decreased to 0 million in 2025Q1 from 70 million in 2024Q4 representing a change of -100.0%. This suggests that the company has been able to collect payments from its customers more efficiently and timely.

  Dividends Paid: Dividends Paid increased to 0 million in 2025Q1 from -19,176 million in 2024Q4 representing a change of 100.0%. This indicates a stronger financial position, more confidence in future prospects, and a better commitment to returning value to shareholders.

Earnings Transcripts ⓘ

No earnings transcripts available.

Earnings Per Share (EPS) ⓘ

Analyst Stock Recommendations ⓘ

Discover detailed analyst recommendations for stocks, including categories such as Buy, Hold, Sell, Strong Buy, and Strong Sell. These insights are based on thorough analysis of financial and market factors. The consensus is calculated by assigning a numerical score to each recommendation. These scores are then weighted and averaged over a specified period to provide a comprehensive view of the stock's outlook, with the final score determining the overall consensus.

Financial Ratios ⓘ

• Annual Financial Ratios

	2024-03-31	2023-03-31	Y/Y change %
FY
calendar year	2023	2022	NaN
revenue per share	837.49	894.05	-6.33
net income per share	140.23	179.02	-21.67
operating cash flow per share	180.88	104.42	73.22
free cash flow per share	124.14	55.03	125.58
cash per share	567.7	555.38	2.22
book value per share	1810.47	1707.97	6.00
tangible book value per share	1800.12	1696.58	6.10
shareholders equity per share	1796.1	1695.19	5.95
interest debt per share	0	5.36	-100.00
market cap	4086081479909	4535894440000	-9.92
enterprise value	3563102479909	4028471440000	-11.55
pe ratio	30.69	26.59	15.40
price to sales ratio	5.14	5.32	-3.50
pocfratio	23.79	45.58	-47.81
pfcf ratio	34.66	86.5	-59.93
pb ratio	2.4	2.81	-14.68
ptb ratio	2.4	2.81	-14.68
ev to sales	4.48	4.73	-5.25
enterprise value over ebitda	18.66	16.75	11.44
ev to operating cash flow	20.74	40.49	-48.76
ev to free cash flow	30.23	76.82	-60.65
earnings yield	0.03	0.04	-13.35
free cash flow yield	0.03	0.01	149.54
debt to equity	0	0.0	-100.00
debt to assets	0	0.0	-100.00
net debt to ebitda	-2.74	-2.11	-29.86
current ratio	6.86	5.77	18.85
interest coverage	0	0	NaN
income quality	1.29	0.43	198.29
dividend yield	0.02	0.02	3.66
payout ratio	0.68	0.57	19.62
sales general and administrative to revenue	0.07	0.11	-34.49
research and ddevelopement to revenue	0.06	0.06	2.74
intangibles to total assets	0.01	0.01	-11.97
capex to operating cash flow	0.31	0.47	-33.68
capex to revenue	0.07	0.06	22.65
capex to depreciation	1.1	0.96	14.93
stock based compensation to revenue	0	0	NaN
graham number	2380.53	2613.03	-8.90
roic	0.06	0.09	-30.07
return on tangible assets	0.07	0.09	-24.12
graham net net	540.78	608.21	-11.09
working capital	919375000000	877785000000	4.74
tangible asset value	1709377000000	1616700000000	5.73
net current asset value	869428000000	815759000000	6.58
invested capital	1536953000000	1477336000000	4.04
average receivables	80693000000	155278500000	-48.03
average payables	49936500000	53204000000	-6.14
average inventory	356561500000	300070500000	18.83
days sales outstanding	0	69.14	-100.00
days payables outstanding	29.63	39.47	-24.93
days of inventory on hand	250.16	243.02	2.94
receivables turnover	0	5.28	-100.00
payables turnover	12.32	9.25	33.21
inventory turnover	1.46	1.5	-2.86
roe	0.08	0.11	-26.07
capex per share	56.74	49.39	14.89

• ROE:

• Positive

  PE Ratio: Price-to-Earnings (P/E) Ratio increased to 30.69 on 2024-03-31 from 26.59 on 2023-03-31, representing a change of 15.40%. Indicating an increase in the relative valuation of the company's stock.

  Debt-to-Equity Ratio: Debt-to-Equity Ratio decreased to 0.00 on 2024-03-31 from 0.00 on 2023-03-31, representing a change of -100.00%. The debt-to-equity ratio has been decreasing, indicating that the company has been relying less on debt financing. A ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

• Negative

  Current Ratio: Current Ratio increased to 6.86 on 2024-03-31 from 5.77 on 2023-03-31, representing a change of 18.85%. The current ratio has been increasing, suggesting an increase in the company's short-term liquidity. Since it's above 3, indicating poor management of working capital.

• Quarterly Financial Ratios

	2024-09-30 Q2	2024-06-30 Q1	Q/Q change %
FANUY
calendar year	2024	2024	NaN
revenue per share	202.43	206.31	-1.88
net income per share	43.16	30.46	41.70
operating cash flow per share	None	0	NaN
free cash flow per share	None	0	NaN
cash per share	597.56	611.96	-2.35
book value per share	1783.97	1845.89	-3.35
tangible book value per share	1774.42	1835.87	-3.35
shareholders equity per share	1769.74	1831.29	-3.36
interest debt per share	0	8.05	-100.00
market cap	3991980600000	4173141918831	-4.34
enterprise value	3438960600000	3618153918831	-4.95
pe ratio	24.27	36.22	-32.99
price to sales ratio	20.7	21.39	-3.23
pocfratio	0	0	NaN
pfcf ratio	0	0	NaN
pb ratio	2.37	2.41	-1.75
ptb ratio	2.37	2.41	-1.75
ev to sales	17.83	18.55	-3.85
enterprise value over ebitda	52.19	80.03	-34.79
ev to operating cash flow	0	0	NaN
ev to free cash flow	0	0	NaN
earnings yield	0.01	0.01	49.24
free cash flow yield	None	0	NaN
debt to equity	0	0.0	-100.00
debt to assets	0	0.0	-100.00
net debt to ebitda	-8.39	-12.28	31.63
current ratio	6.91	7.06	-2.21
interest coverage	0	0	NaN
income quality	0	0	NaN
dividend yield	None	0	NaN
payout ratio	None	0	NaN
sales general and administrative to revenue	0	0	NaN
research and ddevelopement to revenue	0	0	NaN
intangibles to total assets	0.0	0.0	-1.42
capex to operating cash flow	0	0	NaN
capex to revenue	None	0	NaN
capex to depreciation	0	0	NaN
stock based compensation to revenue	None	0	NaN
graham number	1310.93	1120.27	17.02
roic	0.02	0.01	43.57
return on tangible assets	0.02	0.01	46.51
graham net net	661.07	695.84	-5.00
working capital	901825000000	949530000000	-5.02
tangible asset value	1690558000000	1736085000000	-2.62
net current asset value	851633000000	899103000000	-5.28
invested capital	1514910000000	1574279000000	-3.77
average receivables	136622000000	149175000000	-8.41
average payables	38841000000	43160500000	-10.01
average inventory	344723500000	359653500000	-4.15
days sales outstanding	60.35	66.39	-9.09
days payables outstanding	26.54	30.66	-13.44
days of inventory on hand	257.44	252.15	2.10
receivables turnover	1.49	1.36	10.00
payables turnover	3.39	2.94	15.53
inventory turnover	0.35	0.36	-2.05
roe	0.02	0.02	46.62
capex per share	None	0	NaN

• Negative

  ROE: Return on Equity (ROE) decreased to 0.02 on 2024-09-30 Q2 from 0.02 on 2024-06-30 Q1, representing a change of 46.62%. Suggesting that the company has not been generating high returns for its shareholders.

  PE Ratio: Price-to-Earnings (P/E) Ratio decreased to 24.27 on 2024-09-30 Q2 from 36.22 on 2024-06-30 Q1, representing a change of -32.99%. Indicating a decrease in the relative valuation of the company's stock.

  Current Ratio: Current Ratio decreased to 6.91 on 2024-09-30 Q2 from 7.06 on 2024-06-30 Q1, representing a change of -2.21%. The current ratio has been declining, suggesting a decrease in the company's short-term liquidity. Since it's above 3, indicating poor management of working capital.

• Positive

  Debt-to-Equity Ratio: Debt-to-Equity Ratio decreased to 0.00 on 2024-09-30 Q2 from 0.00 on 2024-06-30 Q1, representing a change of -100.00%. The debt-to-equity ratio has been decreasing, indicating that the company has been relying less on debt financing. A ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

Growth Rates ⓘ

• Annual Growth

• Quarterly Growth

Intrinsic Value (Discounted Cash Flow) ⓘ

Positive Sentiment: Discounted Cash Flow value is 22.49 which is higher than current price 15, indicates the company may be undervalued.